CN100551449C - Tussah silk fibroin biomedical material and preparation method thereof - Google Patents
Tussah silk fibroin biomedical material and preparation method thereof Download PDFInfo
- Publication number
- CN100551449C CN100551449C CNB2006101559704A CN200610155970A CN100551449C CN 100551449 C CN100551449 C CN 100551449C CN B2006101559704 A CNB2006101559704 A CN B2006101559704A CN 200610155970 A CN200610155970 A CN 200610155970A CN 100551449 C CN100551449 C CN 100551449C
- Authority
- CN
- China
- Prior art keywords
- silk fibroin
- tussah silk
- solution
- tussah
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 75
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000003519 biomedical and dental material Substances 0.000 title claims description 13
- 239000000463 material Substances 0.000 claims abstract description 27
- 239000000835 fiber Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 11
- 102000008186 Collagen Human genes 0.000 claims abstract description 7
- 108010035532 Collagen Proteins 0.000 claims abstract description 7
- 229920001436 collagen Polymers 0.000 claims abstract description 7
- 238000010041 electrostatic spinning Methods 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 30
- 238000009987 spinning Methods 0.000 claims description 17
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 8
- 230000000996 additive effect Effects 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 235000008708 Morus alba Nutrition 0.000 claims description 6
- 240000000249 Morus alba Species 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 5
- 239000004202 carbamide Substances 0.000 claims description 5
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- 239000004626 polylactic acid Substances 0.000 claims description 5
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 5
- 229920002101 Chitin Polymers 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000004633 polyglycolic acid Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 241000255978 Antheraea pernyi Species 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 238000004090 dissolution Methods 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 235000013877 carbamide Nutrition 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 239000012567 medical material Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 8
- 210000001519 tissue Anatomy 0.000 abstract description 6
- 230000008439 repair process Effects 0.000 abstract description 5
- 230000006698 induction Effects 0.000 abstract description 4
- 239000011148 porous material Substances 0.000 abstract description 4
- 230000021164 cell adhesion Effects 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 210000000845 cartilage Anatomy 0.000 abstract description 2
- 230000010261 cell growth Effects 0.000 abstract description 2
- 210000001951 dura mater Anatomy 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 210000002435 tendon Anatomy 0.000 abstract description 2
- 239000011550 stock solution Substances 0.000 description 9
- 230000009182 swimming Effects 0.000 description 8
- 239000012460 protein solution Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000001523 electrospinning Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- ZJZXSOKJEJFHCP-UHFFFAOYSA-M lithium;thiocyanate Chemical compound [Li+].[S-]C#N ZJZXSOKJEJFHCP-UHFFFAOYSA-M 0.000 description 4
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 3
- 108010013296 Sericins Proteins 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- -1 polygalactone Polymers 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000008149 soap solution Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
Abstract
本发明公开一种生物医学工程材料及其制备方法,特别涉及一种细胞易黏附生长的三维组织修复材料及其制备方法,属生物医用材料技术领域。它以天然柞蚕丝为原料,柞蚕丝素蛋白溶解后,采用静电纺丝方法,得到柞蚕丝素蛋白纤维构成的三维无纺网状结构,纤维直径为50nm~20μm,纤维间孔隙为1~500μm,无纺网厚度为50nm~20mm;柞蚕丝素的分子量为10×104~20×105D。这种生物医学工程材料具有无毒无害,生物相容性良好,细胞黏附生长性能优良的特点,且原料丰富,成本低廉,可望代替高成本的胶原等生物医用材料,用作人工皮肤、肌腱、软骨、硬脑膜等修复材料,特别是组织细胞诱导材料。The invention discloses a biomedical engineering material and a preparation method thereof, in particular to a three-dimensional tissue repair material and a preparation method thereof, which belong to the technical field of biomedical materials. It uses natural tussah silk as raw material. After the tussah silk fibroin is dissolved, the electrostatic spinning method is used to obtain a three-dimensional non-woven network structure composed of tussah silk fibroin fibers. The fiber diameter is 50nm-20μm, and the pores between the fibers are 1-500μm. , the thickness of the non-woven net is 50nm-20mm; the molecular weight of tussah silk fibroin is 10×10 4 ~20×10 5 D. This biomedical engineering material has the characteristics of non-toxic and harmless, good biocompatibility, and excellent cell adhesion and growth performance. It is rich in raw materials and low in cost. It is expected to replace high-cost biomedical materials such as collagen for artificial skin, Repair materials such as tendon, cartilage, and dura mater, especially tissue cell induction materials.
Description
技术领域 technical field
本发明涉及一种生物医学工程材料及其制备方法,特别涉及一种细胞易黏附生长的三维组织修复材料及其制备方法,属生物医用材料技术领域。The invention relates to a biomedical engineering material and a preparation method thereof, in particular to a three-dimensional tissue repair material and a preparation method thereof, which belong to the technical field of biomedical materials.
背景技术 Background technique
柞蚕丝含有大量的Arg-Gly-Asp(精氨酸-乙氨酸-天门冬氨酸,RGD)三肽序列,并且经证明该序列对细胞的黏附有利[Minoura N,Aiba S,Gotoh Y,Tsukada M,Imai Y.Attachment and growth of fibroblast cells on silkfibroin.Biochem Biophys Res Commun,1995,208(2):511-516;PierschbacherMD,Ruoslahti E,[J].Nature,1984,(309):30-33;Pierschbacher MD,RuoslahtiE.Pro Natl Acad Sci USA,1984,(81):5985-5988]。这一点在Sofia[Sofia S,McCarthy MB,Gronowic G,et.al.Biomed Mater Res,2001,(54):139-148.]等的体外细胞培养实验中得以证明。上述公开的研究内容表明,将材料用RGD共价修饰时,细胞在材料上的活性增强,并且促进了类成骨细胞的矿质化,增强了体外骨骼形成的诱导。因此柞蚕丝素有望在作为细胞培养基质、伤口覆盖膜、人造皮肤及组织工程支架材料和生物医用材料改性等方面形成较大的应用研究成果。Tussah silk contains a large amount of Arg-Gly-Asp (arginine-tyrosine-aspartic acid, RGD) tripeptide sequence, and this sequence has been proved to be beneficial for cell adhesion [Minoura N, Aiba S, Gotoh Y, Tsukada M, Imai Y. Attachment and growth of fibroblast cells on silkfibroin. Biochem Biophys Res Commun, 1995, 208 (2): 511-516; PierschbacherMD, Ruoslahti E, [J]. Nature, 1984, (309): 30- 33; Pierschbacher MD, Ruoslahti E. Pro Natl Acad Sci USA, 1984, (81): 5985-5988]. This point was proved in the in vitro cell culture experiment of Sofia [Sofia S, McCarthy MB, Gronowic G, et.al.Biomed Mater Res, 2001, (54): 139-148.]. The above disclosed research content shows that when the material is covalently modified with RGD, the activity of cells on the material is enhanced, the mineralization of osteoblast-like cells is promoted, and the induction of bone formation in vitro is enhanced. Therefore, tussah silk fibroin is expected to form greater application research results in cell culture substrates, wound covering membranes, artificial skin and tissue engineering scaffold materials, and biomedical material modification.
柞蚕是我国的优势资源,柞蚕丝由约80%以上的丝素和不到20%的丝胶所组成,是相当纯的天然蛋白纤维,丝素的氨基酸组成与人体胶原蛋白有一定的相似性,无毒性、无刺激作用、具有良好的生物相容性。因此,柞蚕丝丝素是制备生物医用制品的较理想原料,但由于天然柞蚕丝直径为20μm以上,且较难塑型,所以,天然柞蚕丝素在生物医学领域的应用范围受到很大局限。Tussah silkworm is an advantageous resource in my country. Tussah silk is composed of more than 80% silk fibroin and less than 20% sericin. It is a fairly pure natural protein fiber. The amino acid composition of silk fibroin is similar to human collagen , non-toxic, non-irritating, and has good biocompatibility. Therefore, tussah silk fibroin is an ideal raw material for preparing biomedical products, but because the diameter of natural tussah silk is more than 20 μm, and it is difficult to shape, the application range of natural tussah silk in the field of biomedicine is greatly limited.
天然柞蚕丝素纤维大分子链间有很强的相互作用,含有二硫键,比桑蚕丝素更难溶解,一般溶解桑蚕丝素的溶剂很难溶解柞蚕丝素。在本发明作出之前,题为“柞蚕丝素肽生产技术研究”[辽宁丝绸2001,(3):34-35]一文中,公开了一种将柞蚕丝溶解于磷酸溶液中制得柞蚕丝素肽的方法;公开号为CN1415626A的中国发明专利“柞蚕丝素肽制取方法”中,也公开了一种将柞蚕丝加入到磷酸中,在100~130℃的温度条件下溶解8~10h,制备柞蚕丝素肽的技术方案。采用上述技术方案的原理是丝素蛋白在部分强酸的作用下发生水解断链,使分子量大大降低,生成分子量约在200~5000D的丝素肽,适用于食品和化妆品领域。但由于分子量太小的原因,无法满足制备生物医用材料三维支架塑形和力学性能的要求。The macromolecular chains of natural tussah silk fibroin have strong interactions and contain disulfide bonds, which are more difficult to dissolve than mulberry silk fibroin. Generally, the solvents that dissolve mulberry silk fibroin are difficult to dissolve tussah silk. Before the present invention was made, an article titled "Research on the Production Technology of Tussah Silk Peptide" [Liaoning Silk 2001, (3): 34-35] disclosed a method of dissolving tussah silk in phosphoric acid solution to prepare tussah silk Peptide method; the Chinese invention patent "Preparation Method of Tussah Silk Peptide" with publication number CN1415626A also discloses a method of adding tussah silk to phosphoric acid and dissolving it at a temperature of 100-130°C for 8-10 hours. A technical scheme for preparing tussah silk peptide. The principle of adopting the above technical solution is that silk fibroin is hydrolyzed and broken under the action of some strong acids, so that the molecular weight is greatly reduced, and a silk fibroin peptide with a molecular weight of about 200-5000D is produced, which is suitable for the fields of food and cosmetics. However, because the molecular weight is too small, it cannot meet the requirements for the shaping and mechanical properties of three-dimensional scaffolds prepared for biomedical materials.
发明内容 Contents of the invention
本发明的目的在于克服现有技术存在的不足,提供一种能满足三维支架塑形和力学性能要求、有利于细胞黏附生长的柞蚕丝素蛋白生物医用材料及其制备方法。The purpose of the present invention is to overcome the deficiencies in the prior art, and provide a tussah silk fibroin biomedical material that can meet the three-dimensional scaffold shaping and mechanical performance requirements, and is conducive to cell adhesion and growth, and a preparation method thereof.
本发明采用的技术方案是:一种柞蚕丝素蛋白生物医用材料,它是柞蚕丝素蛋白纤维构成的三维无纺网状结构,纤维直径为50nm~20μm,纤维间孔隙为1~500μm,无纺网厚度为50nm~20mm;它含有10~100%重量的分子量为10×104~20×105D的柞蚕丝素蛋白。The technical solution adopted in the present invention is: a tussah silk fibroin biomedical material, which is a three-dimensional non-woven network structure composed of tussah silk fibroin fibers, the fiber diameter is 50nm-20μm, and the pores between fibers are 1-500μm. The thickness of the spun net is 50nm-20mm; it contains 10-100% by weight of tussah silk fibroin with a molecular weight of 10×10 4 ˜20×10 5 D.
上述技术方案中,余量为添加剂;所述的添加剂为纯桑蚕丝素蛋白、聚乳酸或聚乙烯醇、聚乙二醇、聚羟基乙酸、聚几内酯、纤维素、甲壳素、壳聚糖、胶原、明胶中的一种或它们的组合。In the above-mentioned technical scheme, the balance is an additive; the additive is pure mulberry silk fibroin, polylactic acid or polyvinyl alcohol, polyethylene glycol, polyglycolic acid, polygalactone, cellulose, chitin, chitosan One or a combination of sugar, collagen, gelatin.
上述柞蚕丝素蛋白生物医用材料的制备方法,先将柞蚕丝脱胶,得到纯柞蚕丝素,再进行如下步骤的加工:The preparation method of the above-mentioned tussah silk fibroin biomedical material, first degumming the tussah silk to obtain pure tussah silk fibroin, and then performing the following steps of processing:
①按重量比,硫氰酸锂∶巯基乙醇∶尿素=80~98∶1~10∶1~10制成三元溶液,将纯柞蚕丝素置于上述三元溶液中,在温度为40~100℃的条件下溶解5~70h,提纯后制得纯柞蚕丝素蛋白水溶液,再经干燥,得到分子量为10×104~20×105D的柞蚕丝素蛋白;①According to weight ratio, lithium thiocyanate: mercaptoethanol: urea=80~98:1~10:1~10 is made into ternary solution, and pure tussah silk fibroin is placed in above-mentioned ternary solution, at a temperature of 40~ Dissolve at 100°C for 5-70 hours, purify to obtain pure tussah silk fibroin protein aqueous solution, and then dry to obtain tussah silk fibroin protein with a molecular weight of 10×10 4 to 20×10 5 D;
②将纺丝原液的溶质在溶剂中溶解,溶液终浓度为6~30%,制成纺丝原液;所述纺丝原液的溶质中,含有10~100%重量的步骤①获得的柞蚕丝素蛋白:所述的溶剂为甲酸、六氟异丙醇中的一种;② Dissolving the solute of the spinning stock solution in a solvent, the final concentration of the solution is 6-30%, and making the spinning stock solution; the solute of the spinning stock solution contains 10-100% by weight of the tussah silk fibroin obtained in step ① Protein: the solvent is one of formic acid and hexafluoroisopropanol;
③将上述纺丝原液采用静电纺丝工艺,制得以柞蚕丝素蛋白纤维构成的三维无纺网状结构的生物医用材料。③ Using the above-mentioned spinning dope by an electrospinning process to prepare a biomedical material with a three-dimensional non-woven network structure composed of tussah silk fibroin fibers.
上述技术方案中,所述纺丝原液的溶质中,余量为添加剂;所述的添加剂是纯桑蚕丝素蛋白、聚乳酸或聚乙烯醇、聚乙二醇、聚羟基乙酸、聚几内酯、纤维素、甲壳素、壳聚糖、胶原、明胶中的一种或它们的组合。In the above technical scheme, in the solute of the spinning stock solution, the balance is an additive; the additive is pure mulberry silk fibroin, polylactic acid or polyvinyl alcohol, polyethylene glycol, polyglycolic acid, polygalactone , cellulose, chitin, chitosan, collagen, gelatin or a combination thereof.
本发明技术方案所述的溶剂为甲酸时,甲酸溶液浓度为60~99%,溶解温度为20~80℃,溶解时间为0.5~5h。所述的溶剂为六氟异丙醇时,溶解温度为20~50℃,溶解时间为24~240h。When the solvent described in the technical solution of the present invention is formic acid, the concentration of the formic acid solution is 60-99%, the dissolving temperature is 20-80°C, and the dissolving time is 0.5-5h. When the solvent is hexafluoroisopropanol, the dissolving temperature is 20-50° C., and the dissolving time is 24-240 h.
与现有技术相比,本发明的优点是:Compared with prior art, the advantage of the present invention is:
(1)本发明以柞蚕丝素蛋白为主要原料,保留了天然柞蚕丝素蛋白质良好的生物相容性的优点;具有的三维无纺网状结构形式,可直接用于体内外组织细胞的培养和修复,是理想的组织细胞诱导生物医用材料。(1) The present invention uses tussah silk fibroin as the main raw material, which retains the advantages of good biocompatibility of natural tussah silk fibroin; it has a three-dimensional non-woven network structure, which can be directly used for the cultivation of tissue cells in vivo and in vitro And repair, it is an ideal biomedical material for tissue cell induction.
(2)本发明所提供的三元溶液,较好地解决了柞蚕丝素纤维难溶解的难题,得到了分子量在10×104~20×105D的柞蚕丝素蛋白,能满足制备组织修复材料三维支架塑形和力学性能的要求,为生物医用材料提供了丰富的原料。(2) The ternary solution provided by the present invention better solves the difficult problem of insoluble tussah silk fibroin fiber, and obtains tussah silk fibroin protein with a molecular weight of 10×10 4 to 20×10 5 D, which can meet the requirements of tissue preparation. The requirements for the shape and mechanical properties of three-dimensional scaffolds for repair materials provide abundant raw materials for biomedical materials.
(3)本发明提供的柞蚕丝素蛋白能与其它生物材料共混,有利于充分发挥各材料的特性,构建适合各种人体的组织修复材料。(3) The tussah silk fibroin protein provided by the present invention can be blended with other biological materials, which is beneficial to give full play to the characteristics of each material and construct tissue repair materials suitable for various human bodies.
附图说明 Description of drawings
图1是按本发明技术方案制备的柞蚕丝素蛋白溶液的凝胶电泳图谱,其中,Marker1、Marker2为标样,泳道1样品是浓度为0.75%的柞蚕丝素蛋白水溶液,泳道2样品是浓度为1.5%的柞蚕丝素蛋白水溶液,泳道3样品是浓度为2%的柞蚕丝素蛋白水溶液,泳道4样品是浓度为3%的柞蚕丝素蛋白水溶液。Fig. 1 is the gel electrophoresis spectrum of the tussah silk fibroin protein solution prepared according to the technical scheme of the present invention, wherein, Marker1, Marker2 are standard sample, and swimming lane 1 sample is the tussah silk fibroin protein aqueous solution that concentration is 0.75%, and swimming lane 2 sample is concentration is a 1.5% tussah silk fibroin protein aqueous solution, the sample in swimming lane 3 is an aqueous tussah silk fibroin protein solution with a concentration of 2%, and the sample in swimming lane 4 is an aqueous tussah silk fibroin protein solution with a concentration of 3%.
图2是按本发明技术方案制备的柞蚕丝素蛋白纤维构成的三维无纺网状结构生物医用材料的扫描电镜图。Fig. 2 is a scanning electron micrograph of a three-dimensional non-woven network structure biomedical material composed of tussah silk fibroin fibers prepared according to the technical scheme of the present invention.
具体实施方式 Detailed ways
下面结合附图及实施例对本发明作进一步描述:The present invention will be further described below in conjunction with accompanying drawing and embodiment:
实施例一:Embodiment one:
1、将0.6公斤下脚柞蚕丝(缫丝厂副产品)放入10升浓度为0.05%的碳酸钠水溶液中,煮沸0.5小时,重复处理三次,脱尽丝素外围的丝胶,得到纯柞蚕丝丝素;1. Put 0.6 kg of leftover tussah silk (a by-product of a silk reeling factory) into 10 liters of 0.05% sodium carbonate aqueous solution, boil for 0.5 hours, repeat the treatment three times, and remove the sericin around the fibroin to obtain pure tussah silk white;
2、将自然晾干后的纯柞蚕丝丝素,放入到按重量比硫氰酸锂∶巯基乙醇∶尿素按重量比为80∶5∶5的三元溶液中、在60℃的温度条件下溶解20小时,经过滤、超滤提纯,超声波消泡1小时、干燥后制成纯柞蚕丝素蛋白;2. Put the pure tussah silk fibroin after natural drying into a ternary solution with a weight ratio of lithium thiocyanate: mercaptoethanol: urea of 80:5:5 by weight, at a temperature of 60°C Dissolved under high temperature for 20 hours, purified by filtration and ultrafiltration, ultrasonic defoaming for 1 hour, and dried to make pure tussah silk fibroin;
3、将纯柞蚕丝素蛋白置于甲酸溶液中,在温度为30℃的条件下溶解4小时,溶液终浓度为10%,经过滤、提纯,消泡后制成纺丝原料;3. Put the pure tussah silk fibroin protein in formic acid solution, dissolve it for 4 hours at a temperature of 30°C, the final concentration of the solution is 10%, filter, purify, and defoam to make spinning raw materials;
4、采用静电纺丝方法,接收板到喷丝口距离为10cm,电压为10KV,对上述纺丝原液进行喷纺,获得纯柞蚕丝素蛋白纤维构成的三维无纺网状结构的生物医用材料。4. Using the electrospinning method, the distance from the receiving plate to the spinneret is 10cm, and the voltage is 10KV. The above-mentioned spinning stock solution is spray-spun to obtain a three-dimensional non-woven network structure biomedical material composed of pure tussah silk fibroin fibers .
参见附图1,它是按本实施例技术方案制备的柞蚕丝素蛋白溶液的凝胶电泳图谱,其中,Marker1、Marker2为标样,泳道1样品是浓度为0.75%的柞蚕丝素蛋白水溶液,泳道2样品是浓度为1.5%的柞蚕丝素蛋白水溶液,泳道3样品是浓度为2%的柞蚕丝素蛋白水溶液,泳道4样品是浓度为3%的柞蚕丝素蛋白水溶液。由图1可以看到,对照标样,柞蚕丝素蛋白溶液的分子量分布在100000~2000000D之间,还有部分大于2000000D,分子量较大的柞蚕丝素蛋白原材料可满足制备生物医用材料三维支架塑形和力学性能的要求。Referring to accompanying drawing 1, it is the gel electrophoresis pattern of the tussah silk fibroin protein solution prepared by the technical scheme of the present embodiment, wherein, Marker1, Marker2 are standard sample, and swimming lane 1 sample is the tussah silk fibroin protein aqueous solution that concentration is 0.75%, The sample in swimming lane 2 is an aqueous solution of tussah silk fibroin protein with a concentration of 1.5%, the sample in swimming lane 3 is an aqueous solution of tussah silk fibroin protein with a concentration of 2%, and the sample in swimming lane 4 is an aqueous solution of tussah silk fibroin protein with a concentration of 3%. It can be seen from Figure 1 that compared with the standard sample, the molecular weight distribution of the tussah silk fibroin protein solution is between 100,000 and 2,000,000 D, and some of them are larger than 2,000,000 D. Requirements for shape and mechanical properties.
实施例二:Embodiment two:
1、将1公斤茧层放入20升浓度为0.5%的中性皂溶液中,煮沸2小时,脱尽丝素外围的丝胶,热水充分洗涤后得到纯柞蚕丝丝素;1. Put 1 kg of cocoon layer into 20 liters of neutral soap solution with a concentration of 0.5%, boil it for 2 hours, remove the sericin around the silk fibroin, wash it thoroughly with hot water to obtain pure tussah silk fibroin;
2、将干燥后的纯柞蚕丝丝素置于按重量比硫氰酸锂∶巯基乙醇∶尿素=85∶5∶10的三元溶液中,在温度为40℃的条件下经50小时处理,溶解成柞蚕丝素蛋白溶液,经过滤、透析提纯、干燥成纯柞蚕丝素蛋白;2. Place the dried pure tussah silk fibroin in a ternary solution of lithium thiocyanate: mercaptoethanol: urea = 85:5:10 by weight, and treat it for 50 hours at a temperature of 40°C. Dissolved into tussah silk fibroin protein solution, purified by filtration, dialysis, and dried into pure tussah silk fibroin protein;
3、将按质量比为90∶10的纯柞蚕丝素蛋白和聚乳酸,置于浓度为80%的甲酸溶液中,在温度为50℃的条件下溶解2小时,经过滤提纯,消泡后制成溶液终浓度为10%的纺丝原液;3. Put the pure tussah silk fibroin and polylactic acid with a mass ratio of 90:10 in a formic acid solution with a concentration of 80%, dissolve them for 2 hours at a temperature of 50°C, purify by filtration, and defoam Make the spinning stock solution that the final concentration of solution is 10%;
4、采用静电纺丝法,按照常规条件对上述纺丝原液进行喷纺,获得柞蚕丝素含量为90%的三维无纺网。4. Electrospinning is used to spray the above spinning stock solution according to conventional conditions to obtain a three-dimensional nonwoven web with tussah silk fibroin content of 90%.
参见附图2,按本实施例技术方案制备的柞蚕丝素蛋白纤维构成的三维无纺网结构生物医用材料,在16KV12cm放大5千倍的扫描电镜图,图中纤维经50次概算直径约为0.62μm,孔径在1.61~3.62μm之间。按本发明技术方案,通过控制纺丝原液的终浓度和静电纺丝工艺,可以得到纤维直径为50nm~20μm,纤维间孔隙为1~500μm,无纺网厚度为50nm~20mm的柞蚕丝素蛋白纤维构成的三维无纺网结构生物医用材料。Referring to accompanying drawing 2, the three-dimensional non-woven net structure biomedical material that the tussah silk fibroin protein fiber that prepares according to the technical scheme of this embodiment is made, the scanning electron micrograph of magnifying 5 thousand times at 16KV12cm, in the figure the diameter of the fiber is estimated to be about 50 times through 50 times. 0.62μm, the pore size is between 1.61 and 3.62μm. According to the technical scheme of the present invention, by controlling the final concentration of the spinning stock solution and the electrospinning process, it is possible to obtain tussah silk fibroin with a fiber diameter of 50 nm to 20 μm, interfiber pores of 1 to 500 μm, and a nonwoven web thickness of 50 nm to 20 mm. A three-dimensional non-woven network structure biomedical material composed of fibers.
实施例三:Embodiment three:
1、按实施例一中步骤1的方法制备纯柞蚕丝丝素;1, prepare pure tussah silk fibroin by the method for step 1 in embodiment one;
2、将干燥后的纯柞蚕丝丝素在按重量比硫氰酸锂∶巯基乙醇∶尿素=98∶1∶1的溶液中,在温度为80℃的条件下处理5小时,溶解后得到柞蚕丝素蛋白溶液,经过滤、提纯、干燥成纯柞蚕丝素蛋白;2. Treat the dried pure tussah silk fibroin in a solution of lithium thiocyanate: mercaptoethanol: urea = 98:1:1 by weight at a temperature of 80°C for 5 hours, and obtain tussah silkworm after dissolving Silk fibroin solution, filtered, purified, and dried into pure tussah silk fibroin;
3、将按质量比为80∶20的纯柞蚕丝素蛋白和明胶置于六氟异丙醇溶液中,在温度为20℃的条件下溶解150小时,经过滤、提纯,消泡后制成溶液终浓度为5%的纺丝原料;3. Put pure tussah silk fibroin and gelatin in a mass ratio of 80:20 in hexafluoroisopropanol solution, dissolve at 20°C for 150 hours, filter, purify, and defoam The final concentration of the solution is 5% spinning raw material;
4、用静电纺丝方法,在收板到喷丝口距离为15cm,电压15KV对上述纺丝原液进行喷纺,获得柞蚕丝素含量为80%、明胶含量为20%的纤维构成的三维无纺网结构的生物医用材料。4. Using the electrospinning method, the distance from the receiving plate to the spinneret is 15cm, and the voltage is 15KV to spray the above spinning stock solution to obtain a three-dimensional non-woven fabric composed of fibers with a tussah silk fibroin content of 80% and a gelatin content of 20%. Biomedical materials with spun mesh structure.
按本发明提供的技术方案制备的柞蚕丝素蛋白纤维结构的三维无纺网状生物医用材料,不仅保留了天然柞蚕丝素的蛋白质具有良好的生物相容性的特性,且原料丰富,成本低廉。特别是它的组织细胞诱导功能,可望用于代替高成本的胶原等生物医用材料,作为人工皮肤,肌腱、血管、软骨、韧带、食道、硬脑膜等修复用支架材料或外科修复材料。The three-dimensional non-woven mesh biomedical material of tussah silk fibroin protein fiber structure prepared according to the technical scheme provided by the present invention not only retains the good biocompatibility characteristics of the natural tussah silk fibroin protein, but also has abundant raw materials and low cost . In particular, its tissue cell induction function is expected to be used to replace high-cost collagen and other biomedical materials, as artificial skin, tendons, blood vessels, cartilage, ligaments, esophagus, dura mater and other repair scaffold materials or surgical repair materials.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101559704A CN100551449C (en) | 2006-12-30 | 2006-12-30 | Tussah silk fibroin biomedical material and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101559704A CN100551449C (en) | 2006-12-30 | 2006-12-30 | Tussah silk fibroin biomedical material and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101036802A CN101036802A (en) | 2007-09-19 |
CN100551449C true CN100551449C (en) | 2009-10-21 |
Family
ID=38888110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101559704A Expired - Fee Related CN100551449C (en) | 2006-12-30 | 2006-12-30 | Tussah silk fibroin biomedical material and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100551449C (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274109B (en) * | 2008-05-19 | 2011-05-11 | 福建师范大学 | Method for preparing tussah silk fibroin-high polymer stephanoporate interpenetrating grid shaped bracket material with foaming method |
CN101445546B (en) * | 2008-12-31 | 2011-09-28 | 苏州大学 | Preparation for tussore silk fibroin solution and concentration method thereof |
CN101474430B (en) * | 2009-01-13 | 2013-01-09 | 武汉大学 | Tissue regeneration membrane with bioactivity and preparation method thereof |
BRPI1006250B1 (en) | 2009-03-10 | 2019-12-10 | Medprin Regenerative Medical Tech Co Ltd | dura mater and artificial production method |
CN101579246B (en) * | 2009-05-31 | 2010-12-08 | 苏州大学 | A kind of artificial silk fibroin nanofiber nerve repair catheter and its preparation method |
CN101703799B (en) * | 2009-11-20 | 2014-12-24 | 深圳齐康医疗器械有限公司 | Preparation of anti-coagulation dermis scaffold |
CN101775365A (en) * | 2010-03-29 | 2010-07-14 | 苑国忠 | Invitro tissue cultivation method of hepatocyte of mammal |
CN102133425B (en) * | 2011-03-13 | 2014-05-14 | 苏州大学 | Tussah silk fibroin film and preparation method thereof |
CN102293688B (en) * | 2011-06-03 | 2013-09-04 | 浙江星月生物科技股份有限公司 | Silk stent as well as preparation and application thereof |
CN102691171A (en) * | 2012-05-17 | 2012-09-26 | 南通丝乡丝绸有限公司 | Silk spunbonded non-woven fabric and production process thereof |
CN102850565B (en) * | 2012-08-10 | 2014-01-15 | 浙江大学 | A biomineralization method of tussah silk fibroin that promotes cell growth |
CN103223192B (en) * | 2013-04-03 | 2016-04-20 | 浙江大学 | The preparation method of a kind of fibroin albumen and cyclodextrin composite |
CN103341214B (en) * | 2013-07-08 | 2014-12-31 | 苏州大学 | Silk fibroin membrane and preparation method thereof |
CN103638554B (en) * | 2013-11-13 | 2017-03-15 | 浙江大学 | A kind of fibroin albumen and the preparation method of marine mussel adhesion protein composite |
CN103668782B (en) * | 2013-11-29 | 2016-05-11 | 温州医科大学 | The electrostatic spinning preparation method of the bionical Bruch ' s of ultra-thin porous composite nano fiber film |
CN103820943B (en) * | 2014-03-11 | 2016-04-13 | 武汉大学 | Macropore three-dimensional order orientation silk fibroin nano-fiber support and preparation method thereof |
WO2015163293A1 (en) * | 2014-04-21 | 2015-10-29 | 日立化成株式会社 | Fibroin porous body, fibroin aqueous solution, and fibroin starting material |
CN105079874A (en) * | 2014-05-14 | 2015-11-25 | 复旦大学附属华山医院 | Method for preparing small-diameter artificial blood vessels on basis of nanotechnologies |
KR101573838B1 (en) * | 2014-06-13 | 2015-12-07 | 대한민국 | Artificial biomembrane using Cocoon and Method for manufacturing thereof |
CN108778353A (en) * | 2016-11-18 | 2018-11-09 | 深圳市金新农科技股份有限公司 | Artificial composite membrane, preparation method and applications |
CN107029289A (en) * | 2017-03-31 | 2017-08-11 | 芜湖扬展新材料科技服务有限公司 | A kind of spider silk fibroin tissue renovation material |
CN106975103A (en) * | 2017-03-31 | 2017-07-25 | 芜湖扬展新材料科技服务有限公司 | A kind of spider silk fibroin tissue renovation material containing kuh-seng |
CN107029288A (en) * | 2017-03-31 | 2017-08-11 | 芜湖扬展新材料科技服务有限公司 | A kind of fibroin tissue renovation material containing Chinese violet |
CN107029290A (en) * | 2017-03-31 | 2017-08-11 | 芜湖扬展新材料科技服务有限公司 | A kind of fibroin tissue renovation material containing microcapsules |
CN106823000A (en) * | 2017-03-31 | 2017-06-13 | 芜湖扬展新材料科技服务有限公司 | A kind of fibroin tissue renovation material containing cicada slough |
CN106924808A (en) * | 2017-03-31 | 2017-07-07 | 芜湖扬展新材料科技服务有限公司 | A kind of fibroin tissue renovation material containing the fruit of summer cypress |
CN106983913A (en) * | 2017-03-31 | 2017-07-28 | 芜湖扬展新材料科技服务有限公司 | A kind of fibroin tissue renovation material of chitosan-containing |
CN106983915B (en) * | 2017-05-24 | 2019-09-06 | 南通市第一人民医院 | Silk microfibre-gelatin-polyethylene glycol medical catheter and preparation method thereof |
CN107083580A (en) * | 2017-06-01 | 2017-08-22 | 合肥创沃科技有限公司 | A kind of preparation method of the composite regenerated cellulose tissue repair materials of bamboo nanofiber |
CN107389641B (en) * | 2017-08-01 | 2020-04-07 | 浙江理工大学 | Method for detecting ancient argillized silk fabric based on immune trace method |
CN107812239A (en) * | 2017-09-28 | 2018-03-20 | 广东医科大学 | A kind of preparation method of tussah silk peptide collagen compound rest |
CN107974767A (en) * | 2017-12-29 | 2018-05-01 | 四川省丝绸工程技术研究中心 | A kind of silkworm/tussah silk fibroin composite nano-fiber membrane and preparation method thereof |
CN108532298A (en) * | 2018-04-28 | 2018-09-14 | 袁杰 | A kind of preparation method of anti-hyperblastosis fiber type three-dimensional overlay film frame material |
CN109518299A (en) * | 2018-11-13 | 2019-03-26 | 河南工程学院 | A kind of preparation method of tussah silk peptide/chitosan composite nano fibre |
CN109821072A (en) * | 2019-01-25 | 2019-05-31 | 上海交通大学医学院附属第九人民医院 | A three-phase scaffold for tendon-bone combined with fusion electrospinning three-dimensional printing and coaxial spinning |
CN110841103B (en) * | 2019-11-19 | 2021-02-19 | 华南农业大学 | Mulberry leaf powder-mulberry silk glue/tussah silk fibroin blended membrane and preparation method thereof |
CN111821520B (en) * | 2020-07-08 | 2021-07-13 | 李丹荣 | Skin regeneration material loaded with active bioglass and preparation method thereof |
CN112915256B (en) * | 2021-01-11 | 2022-09-16 | 华南理工大学 | A method for preparing human dura mater repair material with imitative ECM composition and structure by long fiber network skeleton preforming method |
CN114540977B (en) * | 2022-02-19 | 2023-06-23 | 河南工程学院 | Tussah silk fibroin composite nanofiber for wound repair |
CN117258030B (en) * | 2023-11-20 | 2024-02-13 | 苏州恒星医用材料有限公司 | Calotropis gigantea fiber-based hydrogel dressing, and preparation method and application thereof |
-
2006
- 2006-12-30 CN CNB2006101559704A patent/CN100551449C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101036802A (en) | 2007-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100551449C (en) | Tussah silk fibroin biomedical material and preparation method thereof | |
CN103341209B (en) | Silk fibroin nanofiber membrane and preparation method thereof | |
CN103993424B (en) | Preparing method of polyurethane-keratin composite nano fiber film | |
CN103320886B (en) | Bionic regenerated silk fibroin filament fiber and preparation method thereof | |
CN101502671B (en) | Method for preparing silk fibroin/ P(LLA-CL) compound nano fiber structure repair stand | |
CN106267370B (en) | Silk fibroin/cellulose 3D printing ink | |
CN104436285B (en) | A kind of regenerated silk fibroin gel film and its preparation method | |
Li et al. | Silk fibroin scaffolds with a micro-/nano-fibrous architecture for dermal regeneration | |
CN101856510B (en) | Preparation method of composite nano-fiber support material of silk fibroin and calcium silicate | |
Bhattacharjee et al. | Potential of inherent RGD containing silk fibroin–poly (Є-caprolactone) nanofibrous matrix for bone tissue engineering | |
CN100368610C (en) | A kind of silk fibroin and polyvinyl alcohol blended nanofiber and its preparation method | |
CN102102278A (en) | Preparation method of silk fibroin-poly(hydroxybutyrate-hydroxyvalerate) composite fiber membrane | |
CN103341214A (en) | Silk fibroin membrane and preparation method thereof | |
CN104018247B (en) | The preparation method of a kind of urethane-Keratin sulfate composite nano fiber tubular material | |
CN104027846A (en) | Non-woven material reinforced tissue engineering composite three-dimensional scaffold and preparation method thereof | |
CN109529117B (en) | Soluble spraying preparation method of active silk fibroin biological tissue engineering scaffold | |
CN1244727C (en) | Process for producing regenerated silk protein super fine fiber | |
CN104005179A (en) | Method for preparing polycaprolactone-keratin composite nanometer fiber pipe | |
Syed et al. | Current issues and potential solutions for the electrospinning of major polysaccharides and proteins: A review | |
CN109667059B (en) | Method for preparing silk fibroin biological tissue engineering scaffold by solvent spraying | |
CN1372023A (en) | Fibre for tissue engineering scaffold and making method thereof | |
CN102477592A (en) | Biodegradable tissue-engineering fiber | |
Abdu et al. | Selected natural fibers and their electrospinning | |
CN104018245B (en) | A preparation method of silk fibroin/keratin composite nanofiber tubular material | |
WO2020134443A1 (en) | Solution-spraying preparation method for silk fibroin biological tissue engineering stent with optimized mechanical properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091021 Termination date: 20131230 |